Rapid activation of matrix metalloproteinase-2 by glioma cells occurs through a posttranslational MT1-MMP-dependent mechanism

被引:42
作者
Gingras, D
Pagé, M
Annabi, B
Béliveau, R
机构
[1] Hop St Justine, Ctr Canc Charles Bruneau, Lab Mol Med Ste Justine UQAM, Montreal, PQ H3C 3P8, Canada
[2] Univ Quebec, Montreal, PQ H3C 3P8, Canada
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH | 2000年 / 1497卷 / 03期
基金
英国医学研究理事会;
关键词
D O I
10.1016/S0167-4889(00)00071-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Matrix metalloproteinase-2 (MMP-2) has been suggested to play a crucial role in tumor invasion and angiogenesis. In order to understand the mechanisms underlying proMMP-2 activation, we compared the biochemical and cellular events triggered by two potent MMP-2 activators, the lectin concanavalin A (ConA) and the cytoskeleton disrupting agent cytochalasin D (CytoD). Incubation of U87 human glioma cells for 24 h in the presence of ConA or CytoD induced a marked activation of proMMP-2 and this activation was correlated in both cases with an increase in the mRNA levels of MT1-MMP. At the protein level, proMMP-2 activation induced by CytoD or ConA strongly correlated with the appearance of a 43-kDa MT1-MMP proteolytic breakdown product in cell lysates. Interestingly, CytoD also induced a very rapid (2 h) activation of proMMP-2 that was independent of protein synthesis. Under these conditions, CytoD also promoted the rapid proteolytic breakdown of the 63 kDa pro form of MT1-MMP, resulting in the appearance of the 43 kDa MT1-MMP processed form. Overexpression of a recombinant full-length MT1-MMP protein in glioma cells resulted in the activation of proMMP-2 that was correlated with the generation of the 43 kDa fragment of the protein. By contrast, overexpression of the protein in COS-7 cells promoted proMMP-2 activation without inducing the production of the 43 kDa fragment. These results thus suggest that activation of proMMP-2 occurs through both translational and post-translational mechanisms, both involving proteolytic processing of membrane-associated MT1-MMP. This processing of MT1-MMP is, however, not essential to proMMP-2 activation but may represent a regulatory mechanism to control the activity of MT1-MMP. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:341 / 350
页数:10
相关论文
共 28 条
[1]  
AILENBERG M, 1996, BIOCHEM J, V313, P679
[2]   Membrane-type 1 matrix metalloprotease (MT1-MMP) enables invasive migration of glioma cells in central nervous system white matter [J].
Beliën, ATJ ;
Paganetti, PA ;
Schwab, ME .
JOURNAL OF CELL BIOLOGY, 1999, 144 (02) :373-384
[3]   Regulation of matrix metalloproteinase-2 (gelatinase A, MMP-2), membrane-type matrix matelloproteinase-1 (MT1-MMP) and tissue inhibitor of metalloproteinases-2 (TIMP-2) expression by elastin-derived peptides in human HT-1080 fibrosarcoma cell line [J].
Brassart, B ;
Randoux, A ;
Hornebeck, W ;
Emonard, H .
CLINICAL & EXPERIMENTAL METASTASIS, 1998, 16 (06) :489-500
[4]   The TIMP2 membrane type 1 metalloproteinase "receptor" regulates the concentration and efficient activation of progelatinase A - A kinetic study [J].
Butler, GS ;
Butler, MJ ;
Atkinson, SJ ;
Will, H ;
Tamura, T ;
van Westrum, SS ;
Crabbe, T ;
Clements, J ;
d'Ortho, MP ;
Murphy, G .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (02) :871-880
[5]   The propeptide domain of membrane type 1 matrix metalloproteinase is required for binding of tissue inhibitor of metalloproteinases and for activation of pro-gelatinase A [J].
Cao, J ;
Drews, M ;
Lee, HM ;
Conner, C ;
Bahou, WF ;
Zucker, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (52) :34745-34752
[6]  
Deb S, 1999, J NEUROSCI RES, V55, P44, DOI 10.1002/(SICI)1097-4547(19990101)55:1<44::AID-JNR6>3.0.CO
[7]  
2-G
[8]  
Deryugina EI, 1998, CANCER RES, V58, P3743
[9]  
Ellerbroek SM, 1999, CANCER RES, V59, P1635
[10]  
Forget MA, 1999, CAN J PHYSIOL PHARM, V77, P465